摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Phosphoric acid 3-acetyl-phenyl ester (2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester | 180262-52-6

中文名称
——
中文别名
——
英文名称
Phosphoric acid 3-acetyl-phenyl ester (2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester
英文别名
(3-acetylphenyl) [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl hydrogen phosphate
Phosphoric acid 3-acetyl-phenyl ester (2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester化学式
CAS
180262-52-6
化学式
C18H21N2O9P
mdl
——
分子量
440.346
InChiKey
BUTLBMSRWCEYDN-ARFHVFGLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.8
  • 重原子数:
    30
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    152
  • 氢给体数:
    3
  • 氢受体数:
    9

反应信息

  • 作为反应物:
    描述:
    Phosphoric acid 3-acetyl-phenyl ester (2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl estersodium hydroxide 、 sodium tetrahydroborate 作用下, 反应 1.0h, 生成 Phosphoric acid 3-(1-hydroxy-ethyl)-phenyl ester (2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester
    参考文献:
    名称:
    Synthesis and Properties of Combinatorial Libraries of Phosphoramidates
    摘要:
    We have assembled a set of combinatorial libraries of phosphoramidates for pharmacological evaluation. A range of functionalized and unfunctionalized diols, representing a variety of diversity elements, were converted into their corresponding dimethoxytrityl H-phosphonate derivatives which were coupled to each other to produce H-phosphonate dimers and trimers. The H-phosphonate diesters were converted into phosphoramidates by reaction with a wide range of primary and secondary amines. Very large libraries (theoretically, in excess of one million compounds) possessing five sites of diversity were generated for use in our drug discovery program. Smaller libraries with lower molecular weights were also prepared in which only two monomeric units were coupled together and converted into their phosphoramidate derivatives. Methods for the attachment of both radioactive and nonradioactive labels, including (32)phosphorus, tritium, and fluorescein, have been developed. Representative single sequences were also prepared and their chemical properties studied.
    DOI:
    10.1021/jo960192+
  • 作为产物:
    参考文献:
    名称:
    Synthesis and Properties of Combinatorial Libraries of Phosphoramidates
    摘要:
    We have assembled a set of combinatorial libraries of phosphoramidates for pharmacological evaluation. A range of functionalized and unfunctionalized diols, representing a variety of diversity elements, were converted into their corresponding dimethoxytrityl H-phosphonate derivatives which were coupled to each other to produce H-phosphonate dimers and trimers. The H-phosphonate diesters were converted into phosphoramidates by reaction with a wide range of primary and secondary amines. Very large libraries (theoretically, in excess of one million compounds) possessing five sites of diversity were generated for use in our drug discovery program. Smaller libraries with lower molecular weights were also prepared in which only two monomeric units were coupled together and converted into their phosphoramidate derivatives. Methods for the attachment of both radioactive and nonradioactive labels, including (32)phosphorus, tritium, and fluorescein, have been developed. Representative single sequences were also prepared and their chemical properties studied.
    DOI:
    10.1021/jo960192+
点击查看最新优质反应信息

文献信息

  • NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS
    申请人:PHARMAGENICS, INC.
    公开号:EP0880532A1
    公开(公告)日:1998-12-02
  • EP0880532A4
    申请人:——
    公开号:EP0880532A4
    公开(公告)日:1999-06-09
  • US6008398A
    申请人:——
    公开号:US6008398A
    公开(公告)日:1999-12-28
  • [EN] NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS<br/>[FR] OLIGOMERES D'ESTER PHOSPHOREUX NON NUCLEOTIDIQUES
    申请人:PHARMAGENICS, INC.
    公开号:WO1997028168A1
    公开(公告)日:1997-08-07
    (EN) A phosphorus ester oligomer having structure (I) wherein A can be the same or different in each monomeric unit and each is independently selected from the group consisting of oxygen, sulfur, lower alkyl, substituted or unsubstituted alkylamino, substituted or unsubstituted arylamino and aminoalkyl; B1 and B2 can be the same or different and each is independently selected from hydrogen, lower alkyl, a labelling group, a protecting group, a phosphoramidate or a phosphomonoester; R1 can be the same or different in each monomeric unit, and in at least one of the non-nucleotide monomeric units, R1 is independently selected from the group consisting of a condensation product of (i) a non-vicinal diol attached to a hydrogen bond donor functionality; (ii) a hydrogen bond acceptor selected from an ether, a purine or pyrimidine substituted 1,2-diol or a disubstituted heterocycle; (iii) a non-vicinal diol attached to a hydrophobic functionality or a vicinal diol attached to an aliphatic or alicyclic hydrophobic functionality; (iv) a diol attached to a ring substituted anionic functionality and (v) a cationic moiety attached to a non-vicinal or alicyclic diol, any of which can further include a detectable label, and n is at least one. Preferred R1 moieties include condensation products of heterocyclic diols, alicyclic diols, and polycyclic diols. Also the non-nucleotide monomers thereof, combinatorial library mixtures of the oligomers and the use of the oligomers as selective target-binding compounds.(FR) L'invention porte sur un oligomère d'ester phosphoreux présentant la structure (I) dans laquelle: A peut être identique ou différent dans chaque unité monomérique, et chacun des A est choisi indépendamment parmi O, S, alkyle inférieur, alkylamino substitué ou non, arylamino et aminoalkyle substitués ou non; B1 et B2 peuvent être identiques ou différents, et chacun choisi indépendamment parmi H, alkyle inférieure, un groupe marqueur, un groupe protecteur, un phosphoramidate ou un phosphomonoester; R1 peut être identique ou différent dans chaque unité monomère, et au moins dans l'une des unités monomères non nucléotidiques, R1 est choisi indépendamment dans un groupe consistant dans les produits de condensation: (i) d'un diol non vicinal lié à une fonction de donneur de liaison hydrogène, (ii) d'un accepteur de liaison hydrogène choisi parmi un éther, un 1,2-diol à substitution purine ou pyrimidine, ou un hétérocycle disubstitué, (iii) d'un diol non vicinal lié à une fonction hydrophobe, ou d'un diol vicinal lié à une fonction hydrophobe aliphatique ou alicyclique, (iv) d'un diol lié à une fonction anionique à substitution de cycle, et (v) d'un fragment cationique lié à un diol non vicinal ou alicyclique, chacun d'eux pouvant de plus comporter un marqueur détectable; et n étant au moins 1. Les fragments R1 préférés comportent des produits de condensation de diols hétérocycliques, alicycliques ou polycycliques. L'invention porte également sur leurs monomères non nucléotidiques, sur des mélanges de bibliothèques combinatoires d'oligomères, et sur l'emploi d'oligomères comme composés se fixant sélectivement à des cibles.
查看更多

同类化合物

非阿尿苷5’-单磷酸酯 阿拉伯糖基胸腺嘧啶 5'-三磷酸酯 阿拉伯呋喃糖基尿苷三磷酸酯 锂3'-脱氧-5-乙炔基-5'-O-(羟基膦酸)尿苷 苯甲基4-[(4,5-二氢-3-甲基-5-羰基-1-苯基-1H-吡唑-4-基)偶氮]苯酸酯 苯乙酸,4-(1,1-二甲基-2-丙烯基)--α--甲基-(9CI) 苯(甲)醛,O-(4-硝基苯甲酰)肟 脱氧尿苷 5'-三磷酸酯 胸苷酸二钠 胸苷酸 胸苷二磷酸酯-L-鼠李糖 胸苷-5'-三磷酸 胸苷 3',5'-二磷酸酯 胸腺嘧啶脱氧核苷酸5-单磷酸对硝基苯酯钠盐 胞苷酰-(5'-3')-尿苷酰基-(5'-3')-尿苷 胞苷单磷酸酯-N-羟基乙酰基神经氨酸 胞苷5-(三氢二磷酸酯),化合物与2-氨基乙醇(1:1),单钠盐 胞苷5'-四磷酸酯 胞苷5'-单磷酸甲酯 胞苷-5’-二磷酸 胞苷-5’-三磷酸二钠盐 胞苷-5’-三磷酸二钠盐 胞苷-5'-单磷酸-N-乙酰神经氨酸 胞苷-5'-单磷酸-N-乙酰神经氨酸 胞苷-5'-二磷酸三钠 胞苷 5’-单磷酸 胞苷 3',5'-二磷酸酯 胞苷 2ˊ,3ˊ-环一磷酸钠盐 胞磷胆碱钠 胞磷托定 胞嘧啶-5'-二磷酸二钠 胞二磷胆碱 聚尿苷酸钾盐 聚(5-甲硫基尿苷单磷酸) 羟基甲磺基次酸 羟基甲基脱氧尿苷三磷酸酯 磷酸)二氢2'-脱氧-5-(甲氧基甲基)尿苷5'-( 碘脱氧尿苷酸 甲氨蝶呤5-氨基烯丙基-2'-脱氧尿苷5'-单磷酸酯 生物素-36-脱氧三磷酸胞苷 生物素-36-脱氧三磷酸尿苷 环胞苷 5'-磷酸酯 溴脱氧尿苷三磷酸酯 氨基嘧啶酮-4-二磷酸二胺-2-C-甲基-D-赤藓糖醇 尿苷酰基(2'->5')尿苷铵盐 尿苷二磷酸酯葡萄糖胺 尿苷二磷酸酯甘露糖 尿苷二磷酸酯半乳糖胺 尿苷二磷酸酯N-乙酰基-D-氨基甘露醇醛酸盐 尿苷二磷酸酯 N-乙酰基甘露糖胺